Bioxyne Limited (ASX:BXN) Suspension from Quotation

Bioxyne Limited (ASX:BXN) has been suspended from quotation by ASX due to its failure to provide specified information for release to the market in relation to a 2-year manufacture and supply agreement as announced in BXN's previous announcement on 21 August 2024.

ASX Compliance Announcement

Bioxyne Limited (ASX:BXN) has been suspended from quotation by ASX for failing to comply with the requirement to provide specified information related to the manufacture and supply agreement. The suspension will remain in effect until ASX is satisfied with Bioxyne's compliance with the Listing Rules and deems it appropriate for Bioxyne's securities to be reinstated to quotation.

Suspension Impact and Future Outlook

The suspension from quotation by ASX has immediate implications for Bioxyne Limited (ASX:BXN) and its shareholders. It is crucial for Bioxyne to promptly address the ASX's requirement and ensure compliance with the Listing Rules to facilitate the reinstatement of its securities to quotation. The company's ability to meet these obligations will be closely monitored by the market. Bioxyne's future outlook will depend on its ability to rectify the compliance issue and regain the confidence of the market and investors.